Lilly Opens Its Wallet For Early Immunology Tie-Up With ImmuNext

 
• By Jo Shorthouse

Lilly is prepared to splash over $600m on an early development deal with ImmuNext on an immunometabolism target which ties the companies together for three years while an antibody is being developed.

BirdWorm
Lilly is hoping to be the early bird that catches the immunology worm • Source: Shutterstock

More from Deals

More from Business